Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Bone mineral density in ex-thalassemic pediatric patients.

Hamidieh AA, Hamidi Z, Nedaeifard L, Heshmat R, Haralambous H, Alimoghaddam K, Larijani B, Ghavamzadeh A, Mohajeri-Tehrani MR.

Hematol Oncol Stem Cell Ther. 2012;5(1):70-1. doi: 10.5144/1658-3876.2012.71. No abstract available.

2.

Changes of bone density in pediatric patients with β-thalassemia major after allogenic hematopoietic stem cell transplantation.

Hamidieh AA, Hamidi Z, Nedaeifard L, Heshmat R, Alimoghaddam K, Larijani B, Ghavamzadeh A, Mohajeri-Tehrani MR.

Arch Iran Med. 2013 Feb;16(2):88-92. doi: 013162/AIM.008.

3.

Comparison of bone mineral density changes in pediatric thalassemic patients with and without hematopoietic stem cell transplant.

Hamidieh AA, Mohajeri-Tehrani MR, Behfar M, Vaghari-Meher N, Alimoghaddam K, Mohseni F, Ghavamzadeh A, Larijani B, Hamidi Z.

Exp Clin Transplant. 2015 Apr;13(2):173-8. doi: 10.6002/ect.2014.0178. Epub 2014 Nov 12.

4.

Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord.

Miniero R, Rocha V, Saracco P, Locatelli F, Brichard B, Nagler A, Roberts I, Yaniv I, Beksac M, Bernaudin F, Gluckman E.

Bone Marrow Transplant. 1998 Jul;22 Suppl 1:S78-9.

PMID:
9715898
5.

Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.

Iravani M, Tavakoli E, Babaie MH, Ashouri A, Khatami F, Ghavamzadeh A.

Exp Clin Transplant. 2010 Mar;8(1):66-73.

6.

Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.

Tang-naitrisorana Y, Issaragrisil S, Visuthisakchai S, Suvatte V, Piankijakum A.

Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:291-5.

PMID:
8629127
7.

Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.

Iravani M, Mousavi A, Gholibeikian S, Bahar B, Samiee S, Ashouri A, Eghbal L, Ghavamzadeh A.

Bone Marrow Transplant. 2005 Jun;35(11):1095-9.

PMID:
15821773
8.
9.

CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.

Erer B, Polchi P, Lucarelli G, Angelucci E, Baronciani D, Galimberti M, Giardini C, Gaziev D, Maiello A.

Bone Marrow Transplant. 1996 Jul;18(1):157-62.

PMID:
8832009
11.
12.

Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.

Caocci G, Baccoli R, Vacca A, Mastronuzzi A, Bertaina A, Piras E, Littera R, Locatelli F, Carcassi C, La Nasa G.

Exp Hematol. 2010 May;38(5):426-33. doi: 10.1016/j.exphem.2010.02.012. Epub 2010 Mar 4.

PMID:
20206661
13.

Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.

Ghavamzadeh A, Iravani M, Ashouri A, Mousavi SA, Mahdavi N, Shamshiri A, Hadjibabaie M, Namdar R, Nedaeifard L, Ghaffari H, Alimoghaddam K.

Biol Blood Marrow Transplant. 2008 Mar;14(3):301-8. doi: 10.1016/j.bbmt.2007.12.491.

14.

Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience.

Mentzer WC, Cowan MJ.

J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):598-601.

PMID:
11132237
15.

Cord blood transplantation in thalassemia.

Issaragrisil S.

Blood Cells. 1994;20(2-3):259-62; discussion 263. Review.

PMID:
7749104
16.

Pediatric hematopoietic stem cell transplantation in Taiwan.

Lin KH.

Transplant Proc. 1998 Nov;30(7):3477-80. No abstract available.

PMID:
9838527
17.

Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.

Kulkarni S, Powles R, Sirohi B, Treleaven J, Saso R, Horton C, Atra A, Ortin M, Rudin C, Goyal S, Sankpal S, Meller S, Pinkerton CR, Mehta J, Singhal S.

Bone Marrow Transplant. 2003 Jul;32(2):165-70.

PMID:
12838281
18.

Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.

Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.

Transpl Int. 2002 Mar;15(2-3):73-80. Epub 2002 Feb 28.

19.

Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.

Hoyt R, Ritchie DS, Roberts AW, Macgregor L, Curtis DJ, Szer J, Grigg AP.

Bone Marrow Transplant. 2008 Apr;41(7):651-8. doi: 10.1038/sj.bmt.1705955. Epub 2008 Jan 7.

PMID:
18176619
20.

Allogeneic peripheral blood stem cell transplantation in children with homozygous beta-thalassemia and severe beta-thalassemia/hemoglobin E disease.

Pakakasama S, Hongeng S, Chaisiripoomkere W, Chuansumrit A, Sirachainun N, Jootar S.

J Pediatr Hematol Oncol. 2004 Apr;26(4):248-52.

PMID:
15087953

Supplemental Content

Support Center